HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Low-dose growth hormone in adult home parenteral nutrition-dependent short bowel syndrome patients: a positive study.

AbstractBACKGROUND & AIMS:
Controversy surrounds a 3-week treatment with a high-dose (0.14 mg. kg(-1). day(-1)) growth hormone (GH), glutamine, and high carbohydrate diet in home parenteral nutrition (HPN)-dependent patients with short-bowel syndrome (SBS). This study assessed treatment with low-dose GH in these patients.
METHODS:
Twelve adult HPN-dependent (duration, 7 +/- 1 years; mean +/- SEM) patients with SBS (small-bowel remnant length, 48 +/- 11 cm) who were on an unrestricted hyperphagic diet were randomized in a double-blind, placebo-controlled, crossover study. Patients received daily low-dose GH (0.05 mg. kg(-1). day(-1)) and placebo for two 3-week periods separated by a 1-week washout period. Net intestinal absorption of macronutrients was assessed using a duplicate diet; nutritional assessment and blood tests were performed. Data from each group were compared using Wilcoxon rank sum test.
RESULTS:
Treatment with GH increased intestinal absorption of energy (15% +/- 5%, P < 0.002), nitrogen (14% +/- 6%, P < 0.04), carbohydrates (10% +/- 4%, P < 0.04), and fat (12% +/- 8%, NS). The increased food absorption represented 37% +/- 16% of total parenteral energy delivery. Body weight (P < 0.003), lean body mass (P < 0.006), D-xylose absorption (P < 0.02), insulin-like growth factor 1 (P < 0.002), and insulin-like growth factor binding protein 3 (P < 0.002) increased, whereas uptake of GH binding protein decreased (P < 0.01), without any major adverse effect.
CONCLUSIONS:
Three weeks of low-dose GH significantly improved intestinal absorption in HPN-dependent SBS patients who were on a hyperphagic western diet.
AuthorsDavid Seguy, Kouroche Vahedi, Nathalie Kapel, Jean-Claude Souberbielle, Bernard Messing
JournalGastroenterology (Gastroenterology) Vol. 124 Issue 2 Pg. 293-302 (Feb 2003) ISSN: 0016-5085 [Print] United States
PMID12557135 (Publication Type: Clinical Trial, Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't)
Chemical References
  • Dietary Carbohydrates
  • Fats
  • Insulin-Like Growth Factor Binding Protein 3
  • Receptors, Somatotropin
  • Growth Hormone
  • Xylose
  • Nitrogen
Topics
  • Adult
  • Body Composition
  • Body Weight
  • Cross-Over Studies
  • Diet
  • Dietary Carbohydrates (metabolism)
  • Dose-Response Relationship, Drug
  • Energy Metabolism (drug effects)
  • Fats (metabolism)
  • Female
  • Growth Hormone (administration & dosage)
  • Humans
  • Insulin-Like Growth Factor Binding Protein 3 (metabolism)
  • Intestinal Absorption (drug effects)
  • Male
  • Middle Aged
  • Nitrogen (metabolism)
  • Parenteral Nutrition, Home
  • Prospective Studies
  • Receptors, Somatotropin (metabolism)
  • Short Bowel Syndrome (metabolism, pathology, therapy)
  • Xylose (pharmacokinetics)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: